4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Improving digital health literacy in Europe (IC-Health)
Date du début: 1 nov. 2016, Date de fin: 31 oct. 2018,
Citizens' digital health literacy is an essential element for successful eHealth deployment. However, citizens often do not have the necessary skills to find, understand and appraise online health information and apply their knowledge to make health decisions. Digitally health literate citizens are empowered to play a more active role in their health self-management, resulting in improved preventi ...
Voir le projet
14
Participants partenaires
TERMINÉ
First Targeted Therapy to FIGHT Hemophagocytic Lymphohistiocytosis (HLH): A novel approach to HLH (FIGHT-HLH)
Date du début: 1 juil. 2012, Date de fin: 31 juil. 2017,
Hemophagocytic lymphohistiocytosis (HLH) is a rare, devastating disease characterized by uncontrolled immune response that primarily affects young infants and children. HLH is usually fatal if untreated. Even when treated, the overall survival rate is still as low as 60-70%. No drug has been formally developed for the treatment of this disease and current treatment methods require the use of drugs ...
Voir le projet
6
Participants partenaires
TERMINÉ
Regenerating Bone defects using New biomedical Engineering approaches (REBORNE)
Date du début: 1 janv. 2010, Date de fin: 30 juin 2015,
Bone is among the most frequently transplanted tissue with about 1 million procedures annually in Europe. The worldwide market of bone replacement materials is currently estimated at 5 billion € with a 10% annual growth. Despite their considerable disadvantages, including the risk of disease transfer and immunologic rejection, limited supply of bone, costs and complications, allografts and autogra ...
Voir le projet
24
Participants partenaires
TERMINÉ
European initiative to improve knowledge, treatment and survival of haemophagocytic syndromes in children (CureHLH)
Date du début: 1 juin 2008, Date de fin: 31 mai 2011,
Haemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening inherited immune disorder of early childhood characterised by an uncontrolled immune response. Three disease causing genes have been identified in about half of the patients. Diagnosis is difficult, pathophysiology poorly understood, and treatment unsatisfactory with about 40% of the children dying from treatment failure or t ...
Voir le projet